Pentraxin-3 as a marker of disease activity in takayasu arteritis

Annals of Internal Medicine

Volumn 155, Issue 7, 2011, Pages 425-433

  Dagna, Lorenzo ^a   Salvo, Fulvio ^a   Tiraboschi, Mirta ^a   Bozzolo, Enrica P ^a   Franchini, Stefano ^a   Doglioni, Claudio ^a   Manfredi, Angelo A ^a   Baldissera, Elena ^a   Sabbadini, Maria Grazia ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; PENTRAXIN 3;

ADULT; AORTA ARCH SYNDROME; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY;

EID: 80053540384     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-155-7-201110040-00005     Document Type: Article

References (64)

1. Hoffman GS. Takayasu arteritis: lessons from the American National Institutes of Health experience. Int J Cardiol. 1996;54 Suppl:S99-102. [PMID: 9119532]
2. Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, et al. Takayasu arteritis. Ann Intern Med. 1994;120:919-29. [PMID: 7909656]
3. Numano F, Kobayashi Y. Takayasu arteritis-beyond pulselessness. Intern Med. 1999;38:226-32. [PMID: 10337931]
4. Numano F, Kobayashi Y, Maruyama Y, Kakuta T, Miyata T, Kishi Y. Takayasu arteritis: clinical characteristics and the role of genetic factors in its pathogenesis. Vasc Med. 1996;1:227-33. [PMID: 9546941]
5. Rosenthal T, Morag B, Itzchak Y. Takayasu arteritis in Israel. Heart Vessels Suppl. 1992;7:44-7. [PMID: 1360970]
6. Park YB, Hong SK, Choi KJ, Sohn DW, Oh BH, Lee MM, et al. Takayasu arteritis in Korea: clinical and angiographic features. Heart Vessels Suppl. 1992;7:55-9. [PMID: 1360972]
7. Koide K. Takayasu arteritis in Japan. Heart Vessels Suppl. 1992;7:48-54. [PMID: 1360971]
8. Türkoǧlu C, Memiş A, Payzin S, Akin M, Kültüsay H, Akilli A, et al. Takayasu arteritis in Turkey. Int J Cardiol. 1996;54 Suppl:S135-6. [PMID: 9119514]
9. Sato EI, Hatta FS, Levy-Neto M, Fernandes S. Demographic, clinical, and angiographic data of patients with Takayasu arteritis in Brazil. Int J Cardiol. 1998;66 Suppl 1:S67-70. [PMID: 9951804]
10. Cañas CA, Jimenez CA, Ramirez LA, Uribe O, Tobón I, Torrenegra A, et al. Takayasu arteritis in Colombia. Int J Cardiol. 1998;66 Suppl 1:S73-9. [PMID: 9951805]
11. Robles M, Reyes PA. Takayasu's arteritis in Mexico: a clinical review of 44 consecutive cases. Clin Exp Rheumatol. 1994;12:381-8. [PMID: 7955601]
12. Vanoli M, Daina E, Salvarani C, Sabbadini MG, Rossi C, Bacchiani G, et al; Itaka Study Group. Takayasu's arteritis: a study of 104 Italian patients. Arthritis Rheum. 2005;53:100-7. [PMID: 15696576]
13. Mwipatayi BP, Jeffery PC, Beningfield SJ, Matley PJ, Naidoo NG, Kalla AA, et al. Takayasu arteritis: clinical features and management: report of 272 cases. ANZ J Surg. 2005;75:110-7. [PMID: 15777385]
14. Hoffman GS, Ahmed AE. Surrogate markers of disease activity in patients with Takayasu arteritis. A preliminary report from The International Network for the Study of the Systemic Vasculitides (INSSYS). Int J Cardiol. 1998;66 Suppl 1:S191-4. [PMID: 9951819]
15. Tripathy NK, Sinha N, Nityanand S. Interleukin-8 in Takayasu's arteritis: plasma levels and relationship with disease activity. Clin Exp Rheumatol. 2004;22:S27-30. [PMID: 15675131]
16. Tripathy NK, Sinha N, Nityanand S. Anti-annexin V antibodies in Takayasu's arteritis: prevalence and relationship with disease activity. Clin Exp Immunol. 2003;134:360-4. [PMID: 14616799]
17. Tripathy NK, Sinha N, Nityanand S. Antimonocyte antibodies in Takayasu's arteritis: prevalence of and relation to disease activity. J Rheumatol. 2003;30:2023-6. [PMID: 12966610]
18. Lupi-Herrera E, Sánchez-Torres G, Marcushamer J, Mispireta J, Horwitz S, Vela JE. Takayasu's arteritis. Clinical study of 107 cases. Am Heart J. 1977;93:94-103. [PMID: 12655]
19. Garlanda C, Bottazzi B, Bastone A, Mantovani A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol. 2005;23:337-66. [PMID: 15771574]
20. Doni A, Peri G, Chieppa M, Allavena P, Pasqualini F, Vago L, et al. Production of the soluble pattern recognition receptor PTX3 by myeloid, but not plasmacytoid, dendritic cells. Eur J Immunol. 2003;33:2886-93. [PMID: 14515272]
21. Mantovani A, Garlanda C, Doni A, Bottazzi B. Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3. J Clin Immunol. 2008;28:1-13. [PMID: 17828584]
22. Mantovani A, Garlanda C, Bottazzi B, Peri G, Doni A, Martinez de la Torre Y, et al. The long pentraxin PTX3 in vascular pathology. Vascul Pharmacol. 2006;45:326-30. [PMID: 17023219]
23. Luchetti MM, Piccinini G, Mantovani A, Peri G, Matteucci C, Pomponio G, et al. Expression and production of the long pentraxin PTX3 in rheumatoid arthritis (RA). Clin Exp Immunol. 2000;119:196-202. [PMID: 10606983]
24. Fazzini F, Peri G, Doni A, Dell'Antonio G, Dal Cin E, Bozzolo E, et al. PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation. Arthritis Rheum. 2001;44:2841-50. [PMID: 11762945]
25. Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990;33:1129-34. [PMID: 1975175]
26. Peri G, Introna M, Corradi D, Iacuitti G, Signorini S, Avanzini F, et al. PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. Circulation. 2000;102:636-41. [PMID: 10931803]
27. Vouret-Craviari V, Matteucci C, Peri G, Poli G, Introna M, Mantovani A. Expression of a long pentraxin, PTX3, by monocytes exposed to the mycobacterial cell wall component lipoarabinomannan. Infect Immun. 1997;65:1345-50. [PMID: 9119472]
28. Maksimowicz-McKinnon K, Clark TM, Hoffman GS. Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients. Arthritis Rheum. 2007;56:1000-9. [PMID: 17328078]
29. Hoffman GS, Merkel PA, Brasington RD, Lenschow DJ, Liang P. Antitumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. Arthritis Rheum. 2004;50:2296-304. [PMID: 15248230]
30. Tso E, Flamm SD, White RD, Schvartzman PR, Mascha E, Hoffman GS. Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment. Arthritis Rheum. 2002;46:1634-42. [PMID: 12115196]
31. Vergara IA, Norambuena T, Ferrada E, Slater AW, Melo F. StAR: a simple tool for the statistical comparison of ROC curves. BMC Bioinformatics. 2008;9:265. [PMID: 18534022]
32. Alles VV, Bottazzi B, Peri G, Golay J, Introna M, Mantovani A. Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes. Blood. 1994;84:3483-93. [PMID: 7949102]
33. Jaillon S, Peri G, Delneste Y, Frémaux I, Doni A, Moalli F, et al. The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps. J Exp Med. 2007;204:793-804. [PMID: 17389238]
34. Breviario F, d'Aniello EM, Golay J, Peri G, Bottazzi B, Bairoch A, et al. Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component. J Biol Chem. 1992;267:22190-7. [PMID: 1429570]
35. Luchetti MM, Sambo P, Majlingová P, Svegliati Baroni S, Peri G, Paroncini P, et al. Scleroderma fibroblasts constitutively express the long pentraxin PTX3. Clin Exp Rheumatol. 2004;22:S66-72. [PMID: 15344601]
36. Rusnati M, Camozzi M, Moroni E, Bottazzi B, Peri G, Indraccolo S, et al. Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis. Blood. 2004;104:92-9. [PMID: 15031207]
37. Abderrahim-Ferkoune A, Bezy O, Chiellini C, Maffei M, Grimaldi P, Bonino F, et al. Characterization of the long pentraxin PTX3 as a TNFalphainduced secreted protein of adipose cells. J Lipid Res. 2003;44:994-1000. [PMID: 12611905]
38. Aubert S, Bonnet N, Leprince P, Barreda T, Pavie A, Gandjbakhch I. Surgical approach to aortic root lesions in patients with homozygous familial hypercholesterolemia and Takayasu arteritis. J Thorac Cardiovasc Surg. 2005;130:573-4. [PMID: 16077435]
39. Salustri A, Garlanda C, Hirsch E, De Acetis M, Maccagno A, Bottazzi B, et al. PTX3 plays a key role in the organization of the cumulus oophorus extracellular matrix and in in vivo fertilization. Development. 2004;131:1577-86. [PMID: 14998931]
40. Savchenko A, Imamura M, Ohashi R, Jiang S, Kawasaki T, Hasegawa G, et al. Expression of pentraxin 3 (PTX3) in human atherosclerotic lesions. J Pathol. 2008;215:48-55. [PMID: 18220316]
41. Norata GD, Garlanda C, Catapano AL. The long pentraxin PTX3: a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases. Trends Cardiovasc Med. 2010;20:35-40. [PMID: 20656213]
42. Presta M, Camozzi M, Salvatori G, Rusnati M. Role of the soluble pattern recognition receptor PTX3 in vascular biology. J Cell Mol Med. 2007;11:723-38. [PMID: 17760835]
43. Napoleone E, Di Santo A, Bastone A, Peri G, Mantovani A, de Gaetano G, et al. Long pentraxin PTX3 upregulates tissue factor expression in human endothelial cells: a novel link between vascular inflammation and clotting activation. Arterioscler Thromb Vasc Biol. 2002;22:782-7. [PMID: 12006390]
44. Park MC, Lee SW, Park YB, Lee SK. Serum cytokine profiles and their correlations with disease activity in Takayasu's arteritis. Rheumatology (Oxford). 2006;45:545-8. [PMID: 16352633]
45. Rovere P, Peri G, Fazzini F, Bottazzi B, Doni A, Bondanza A, et al. The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells. Blood. 2000;96:4300-6. [PMID: 11110705]
46. Camozzi M, Zacchigna S, Rusnati M, Coltrini D, Ramirez-Correa G, Bottazzi B, et al. Pentraxin 3 inhibits fibroblast growth factor 2-dependent activation of smooth muscle cells in vitro and neointima formation in vivo. Arterioscler Thromb Vasc Biol. 2005;25:1837-42. [PMID: 16020751]
47. Napoleone E, di Santo A, Peri G, Mantovani A, de Gaetano G, Donati MB, et al. The long pentraxin PTX3 up-regulates tissue factor in activated monocytes: another link between inflammation and clotting activation. J Leukoc Biol. 2004;76:203-9. [PMID: 15226367]
48. Gravanis MB. Giant cell arteritis and Takayasu aortitis: morphologic, pathogenetic and etiologic factors. Int J Cardiol. 2000;75 Suppl 1:S21-33. [PMID: 10980333]
49. Sharma BK, Jain S, Radotra BD. An autopsy study of Takayasu arteritis in India. Int J Cardiol. 1998;66 Suppl 1:S85-90. [PMID: 9951807]
50. Pryshchep O, Ma-Krupa W, Younge BR, Goronzy JJ, Weyand CM. Vesselspecific Toll-like receptor profiles in human medium and large arteries. Circulation. 2008;118:1276-84. [PMID: 18765390]
51. Deng J, Ma-Krupa W, Gewirtz AT, Younge BR, Goronzy JJ, Weyand CM. Toll-like receptors 4 and 5 induce distinct types of vasculitis. Circ Res. 2009;104:488-95. [PMID: 19150884]
52. Kerr GS. Takayasu's arteritis. Rheum Dis Clin North Am. 1995;21:1041-58. [PMID: 8592736]
53. Holley L, Woodland N, Hung WT, Cordatos K, Reuben A. Influence of fibrinogen and haematocrit on erythrocyte sedimentation kinetics. Biorheology. 1999;36:287-97. [PMID: 10690265]
54. Kameneva MV, Antaki JF, Watach MJ, Borovetz HS, Kormos RL. Heparin effect on red blood cell aggregation. Biorheology. 1994;31:297-304. [PMID: 8729489]
55. Legouffe E, Rodriguez C, Picot MC, Richard B, Klein B, Rossi JF, et al. C-reactive protein serum level is a valuable and simple prognostic marker in non Hodgkin's lymphoma. Leuk Lymphoma. 1998;31:351-7. [PMID: 9869199]
56. Morley JJ, Kushner I. Serum C-reactive protein levels in disease. Ann N Y Acad Sci. 1982;389:406-18. [PMID: 6953917]
57. Nozoe T, Matsumata T, Kitamura M, Sugimachi K. Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer. Am J Surg. 1998;176:335-8. [PMID: 9817250]
58. Dhingra R, Gona P, Nam BH, D'Agostino RB Sr, Wilson PW, Benjamin EJ, et al. C-reactive protein, inflammatory conditions, and cardiovascular disease risk. Am J Med. 2007;120:1054-62. [PMID: 18060926]
59. Steel DM, Whitehead AS. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today. 1994;15:81-8. [PMID: 8155266]
60. Noris M, Daina E, Gamba S, Bonazzola S, Remuzzi G. Interleukin-6 and RANTES in Takayasu arteritis: a guide for therapeutic decisions? Circulation. 1999;100:55-60. [PMID: 10393681]
61. Matsuyama A, Sakai N, Ishigami M, Hiraoka H, Kashine S, Hirata A, et al. Matrix metalloproteinases as novel disease markers in Takayasu arteritis. Circulation. 2003;108:1469-73. [PMID: 12952836]
62. Koga T, Nishino Y, Makiyama J, Hayashida T, Miyashita T, Izumi Y, et al. Serum amyloid A is a useful marker to evaluate the disease activity of Takayasu's arteritis. Rheumatol Int. 2010;30:561-3. [PMID: 20020137]
63. Pipitone N, Versari A, Salvarani C. Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update. Rheumatology (Oxford). 2008;47:403-8. [PMID: 18292120]
64. Gotway MB, Araoz PA, Macedo TA, Stanson AW, Higgins CB, Ring EJ, et al. Imaging findings in Takayasu's arteritis. AJR Am J Roentgenol. 2005;184:1945-50. [PMID: 15908559]